Chemicals and Drugs

Emtricitabine Tenofovir Disoproxil Fumarate Drug Combination Efavirenz

Inhibitor of reverse transcriptases or of RNA-directed DNA polymerases.

National Library of MedicineMedical Subject Headings2026

Structured Summary

Abstract

Inhibitor of reverse transcriptases or of RNA-directed DNA polymerases.

MeSH Record

Classification

Related Concepts

Knowledge Graph

Loading graph…

Drag nodes to rearrange; hover to trace links; click a node to open its page.

Drug Class

Pharmacological Action

MeSH Record

See Also

MeSH Record

Synonyms

2 entry terms
  • Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
  • Atripla

MeSH Record

Aspects Covered

25 allowable subheadings

Indexed with the subheadings administration & dosage, adverse effects, agonists, analogs & derivatives, analysis, antagonists & inhibitors, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, economics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, urine.

MeSH Record

History Note

2016 (2007)

MeSH Hierarchy

Tree Numbers

AMA Style

References

  1. National Library of Medicine. Emtricitabine Tenofovir Disoproxil Fumarate Drug Combination Efavirenz. Medical Subject Headings (MeSH). 2026. Unique ID D000068257. http://id.nlm.nih.gov/mesh/2026/D000068257
  2. Emtricitabine Tenofovir Disoproxil Fumarate Drug Combination Efavirenz. In: Wikipedia. https://en.wikipedia.org/wiki/Efavirenz/emtricitabine/tenofovir
  3. Emtricitabine Tenofovir Disoproxil Fumarate Drug Combination Efavirenz. In: Wikidata. https://www.wikidata.org/wiki/Q2869808